Sign Up to like & get
recommendations!
0
Published in 2020 at "Antibiotics"
DOI: 10.3390/antibiotics9070418
Abstract: The number of antibacterial agents in clinical and preclinical development possessing activity against a narrow spectrum of bacterial pathogens is increasing, with many of them being nontraditional products. The key value proposition hinges on sparing…
read more here.
Keywords:
narrow spectrum;
benefits challenges;
antibacterial agents;
agents benefits ... See more keywords